BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 30109642)

  • 1. Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System.
    Schonhofen P; Bristot IJ; Crippa JA; Hallak JEC; Zuardi AW; Parsons RB; Klamt F
    CNS Drugs; 2018 Aug; 32(8):697-712. PubMed ID: 30109642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Targets of Cannabidiol in Neurological Disorders.
    Ibeas Bih C; Chen T; Nunn AV; Bazelot M; Dallas M; Whalley BJ
    Neurotherapeutics; 2015 Oct; 12(4):699-730. PubMed ID: 26264914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis and Neuropsychiatric Disorders: An Updated Review.
    Chayasirisobhon S
    Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons.
    Straiker A; Dvorakova M; Zimmowitch A; Mackie K
    Mol Pharmacol; 2018 Jul; 94(1):743-748. PubMed ID: 29669714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
    Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
    Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
    [No Abstract]   [Full Text] [Related]  

  • 7. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.
    Galve-Roperh I; Chiurchiù V; Díaz-Alonso J; Bari M; Guzmán M; Maccarrone M
    Prog Lipid Res; 2013 Oct; 52(4):633-50. PubMed ID: 24076098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the Endocannabinoid System.
    Lu HC; Mackie K
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):607-615. PubMed ID: 32980261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoylethanolamide: A Potential Alternative to Cannabidiol.
    Clayton P; Subah S; Venkatesh R; Hill M; Bogoda N
    J Diet Suppl; 2023; 20(3):505-530. PubMed ID: 34842030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis.
    Dochez-Arnault J; Desdoits-Lethimonier C; Matias I; Evrard B; Lagarrigue M; Toupin M; Lardenois A; Chalmel F; Mazaud-Guittot S; Dejucq-Rainsford N; Gely-Pernot A
    BMC Med; 2023 Jul; 21(1):219. PubMed ID: 37430350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?
    Maccarrone M; Maldonado R; Casas M; Henze T; Centonze D
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):443-455. PubMed ID: 28276775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis and Endocannabinoid Signaling in Epilepsy.
    Katona I
    Handb Exp Pharmacol; 2015; 231():285-316. PubMed ID: 26408165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Treatment with Cannabidiol-Enriched
    Aguiar AFL; Campos RMP; Isaac AR; Paes-Colli Y; Carvalho VM; Sampaio LS; de Melo Reis RA
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Druggable Targets in Endocannabinoid Signaling.
    Gregus AM; Buczynski MW
    Adv Exp Med Biol; 2020; 1274():177-201. PubMed ID: 32894511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond THC and Endocannabinoids.
    Pacher P; Kogan NM; Mechoulam R
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():637-659. PubMed ID: 31580774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health.
    Karimian Azari E; Kerrigan A; O'Connor A
    J Diet Suppl; 2020; 17(5):625-650. PubMed ID: 32677481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical Use of Cannabinoids.
    Fraguas-Sánchez AI; Torres-Suárez AI
    Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.
    Maccarrone M; Di Marzo V; Gertsch J; Grether U; Howlett AC; Hua T; Makriyannis A; Piomelli D; Ueda N; van der Stelt M
    Pharmacol Rev; 2023 Sep; 75(5):885-958. PubMed ID: 37164640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.